Recently, FSH-R expression has been shown in the endothelium of blood vessels from malignant tumors and metastases, including prostate, urothelial, and breast carcinomas, and this suggests a role in neoangiogenesis [14,15,16]. The gene discussed is FSHR; the disease is cancer.